Inventor
CHENGYUAN LIANG
Inventor
CN
Overview
Patents· 20 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations23%
C07DHeterocyclic compounds19%
A61KPreparations for medical, dental or toiletry purposes17%
C07CAcyclic or carbocyclic compounds13%
Y02ATechnologies for adaptation to climate change6%
C07BGeneral methods of organic chemistry4%
C07KPeptides4%
A23FCoffee2%
B01JChemical or physical processes, e.g. catalysis or colloid chemistry2%
C08JWorking-up2%
PatentTitleYear
12,304,917Pleuromutilin derivative containing a thiazolo[5,4-c]pyridine side chain, and a preparation method and application thereof202512,275,734Pleuromutilin onium salt derivative containing a 3H-imidazo[4,5-c]pyridine side chain, and a preparation method and application thereof202512,221,4243-tetrazolylmethyl-1,3,5-triazin-2,4-dione compound inhibiting coronavirus 3CL protease activity and preparation method and use thereof202512,201,665Polygoni Milletii Rhizome compositions and methods of preparing the same202511,872,202Pleuromutilin cinnamic acid ester compounds with activities against antibiotic-resistant infections202411,712,457None202311,639,516Hydroxytyrosol sturgeon skin gelatin film with antioxidant activity and 202311,612,6033-triazolyl methyl-1,3,5-triazine-2,4-dione compounds and preparation method and application thereof202311,597,714Pleuromulin lipoic acid ester with antibacterial activity and a method of preparing the same202311,555,016Pleuromulin 7-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid ester with antibacterial activity and a method of preparing the same202311,530,195Protacs targeting coronavirus 3CL protease and preparation method and application thereof202211,518,740Pleuromutilin (phenylthio)acetic acid ester with anti-drug resistant bacteria activity and a method of preparing the same202211,518,759Protacs based on VHL ligand targeting coronavirus 3CL protease and preparation method and application thereof202211,510,905Pleuromutilin (E)-4-(1-imidazoylmethyl)cinnamic acid ester with anti-drug resistant bacteria activity and a method of preparing the same202211,512,049Pleuromutilin 2-[(diphenylmethyl)thio] acetic acid ester with anti-drug resistant bacteria activity and a method of preparing the same202211,376,299Lilac ginkgo brick tea and method of preparing the same202211,332,430Pleuromulin lauric acid ester with antibacterial activity and a method of preparing the same202211,306,076Silibinin lipoic acid ester with hepatoprotective activity and a method of preparing the same202211,168,049Pleuromulin tretinoin ester with antibacterial activity and a method of preparing the same202111,155,514Pleuromulin acitretin ester with antibacterial activity and a method of preparing the same2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2024Patents assigned to LIANG CHENGYUAN (13)· patent assignee history
2021–2025Patents assigned to UNIV SHAANXI SCIENCE & TECH (11)· patent assignee history
2021–2023Patents assigned to LI HAN (10)· patent assignee history
2021–2024Patents assigned to LI JINGYI (10)· patent assignee history
2021–2024Patents assigned to XIN LIANG (10)· patent assignee history
2021–2025Based in CN· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| LIANG CHENGYUANself | 13 | 2021–2024 |
| UNIV SHAANXI SCIENCE & TECH | 11 | 2021–2025 |
| LI HAN | 10 | 2021–2023 |
| LI JINGYI | 10 | 2021–2024 |
| XIN LIANG | 10 | 2021–2024 |
Locations
| Location | Patents | Span |
|---|---|---|
| CN | 20 | 2021–2025 |